A detailed history of North Star Investment Management Corp. transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, North Star Investment Management Corp. holds 4,415 shares of VKTX stock, worth $186,533. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,415
Previous 2,325 89.89%
Holding current value
$186,533
Previous $123,000 126.83%
% of portfolio
0.02%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$49.84 - $70.47 $104,165 - $147,282
2,090 Added 89.89%
4,415 $279,000
Q2 2024

Aug 05, 2024

BUY
$47.39 - $80.2 $24,879 - $42,105
525 Added 29.17%
2,325 $123,000
Q1 2024

Apr 30, 2024

BUY
$17.4 - $94.5 $31,319 - $170,100
1,800 New
1,800 $147,000

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $3.24B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track North Star Investment Management Corp. Portfolio

Follow North Star Investment Management Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

News

Stay updated on North Star Investment Management Corp. with notifications on news.